Study Objective
To examine adolescent and young adults’ priorities, values and preferences affecting the choice to use intrauterine contraception (IUC).
Design and participants
Qualitative exploratory semi-structured interviews with 27 females 16–25 years old on the day of their IUC insertion. Analysis was done using a modified grounded theory approach.
Setting
Outpatient adolescent medicine clinic located within an academic children’s hospital in the Bronx, New York
Results
We identified four broad factors affecting choice: (1) personal, (2) IUC device-specific, (3) health care provider (HCP), and (4) social network. The majority of the participants perceived an ease with a user-independent method and were attracted by the IUC’s high efficacy, potential longevity of use and the option to remove the device prior to its’ expiration. Participants described their HCP as being the most influential individual during the IUC decision-process via provision of reliable, accurate contraceptive information and demonstration of an actual device. Of all people in their social network, mothers played the biggest role.
Conclusions
Adolescents and young women choosing IUC appear to value IUCs’ efficacy and convenience, their relationship with and elements of clinicians’ contraceptive counseling, and their mother’s support. Our results suggest that during IUC counseling, clinicians should discuss these device-specific benefits, elicit patient questions and concerns, and use visual aids including the device itself. Incorporating the factors we found most salient into routine IUC counseling may increase the number of adolescents and young women who choose IUC as a good fit for them.
Purpose of review
Mycoplasma genitalium (M. genitalium) and Trichomonas vaginalis (T. vaginalis), sexually transmitted infections that remain non-reportable in the United States, may lead to pelvic inflammatory disease (PID) and adverse pregnancy outcomes if left untreated. Prevalence estimates have highlighted socioeconomic and racial/ethnic disparities in rates of infection. This review summarizes the recent literature on M. genitalium and T. vaginalis with a focus on the epidemiology, screening, and treatment of M. genitalium and T. vaginalis.
Recent findings
The burden of T. vaginalis testing remains on women. Antimicrobial resistance is of great concern for M. genitalium. Comprehensive screening and treatment guidelines present an opportunity to address these public health concerns.
Summary
M. genitalium and T. vaginalis infections disproportionately affect sexual and racial/ethnic minorities and those facing socioeconomic disparities. The availability of nucleic acid amplification test testing has facilitated accurate diagnosis of both disorders. Safe and efficacious treatments are available for treatment of both disorders. Integrating macrolide resistance testing into treatment algorithms for M. genitalium and dual antibiotic therapy may prove a useful strategy for future US-based guidance. Public health reporting and increased public awareness campaigns are key next steps to addressing the observed reproductive health disparities.
Civic engagement is positively associated with important health and developmental benefits for participating adolescents and young adults. As illustrated by youth political participation, social activism, and rallies for racial justice during the COVID-19 pandemic, youth civic engagement is often inspired by and responsive to problems that are salient to a young person’s lived experiences. Providers can empower youth and encourage civic engagement by eliciting issues that are important to them and directing them to community resources and opportunities for civic participation that can help them address these issues.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.